Korean J Blood Transfus.  2007 Apr;18(1):1-8.

The Efficiency of Plasma Exchange for Renal Allograft Recipients with HLA Antibody before Transplantation

Affiliations
  • 1Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea. hyunok1019@yumc.yonsei.ac.kr
  • 2Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.

Abstract

BACKGROUND: Therapeutic plasma exchange (TPE) is used to remove antibodies from the blood stream, thereby preventing them from attacking their targets. We evaluated the strategies to increase the efficiency of TPE for renal allograft recipients with HLA antibody.
METHODS
A total of 11 patients were evaluated from January 2002 to April 2004. All the patients had been diagnosed with end stage renal disease (ESRD) and then they were scheduled for renal transplantation from a living unrelated donor or a living related donor. TPE was performed for all lymphocyte cross-matching (LCM) positive recipients before renal transplantation. One to three sessions of TPE were performed in 8 patients and four to seven sessions of TPE were performed in 3 patients (mean: 2.81 times). We used normal saline and 4% albumin as a replacement solution.
RESULTS
Eleven patients, after the patients' LCM positive serum converted to negative, received the renal transplantation. Of the 11 recipients, only 1 recipient suffered from chronic rejection. Ten recipients maintained normal renal function. Among the 11 recipients, 4 recipients were diagnosed with posttransplantation diabetes mellitus. 3 recipients had a past history of graft failure via acute or chronic rejection. Even these 3 recipients experienced successful renal allograft through pre-transplantation TPE. Also, all the recipients were followed up until June, 2005.
CONCLUSION
For ESRD patients with positive LCM, pre-transplantation TPE dramatically decreases the incidence of acute or chronic rejections by converting positive LCM into negative LCM.

Keyword

Therapeutic plasma exchange; Lymphocyte cross-matching; Renal allograft; End stage renal disease

MeSH Terms

Allografts*
Antibodies
Diabetes Mellitus
Humans
Incidence
Kidney Failure, Chronic
Kidney Transplantation
Lymphocytes
Plasma Exchange*
Plasma*
Rivers
Tissue Donors
Transplants
Unrelated Donors
Antibodies
Full Text Links
  • KJBT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr